IDENTIFICATION OF NOVEL REDUCED PYRIDINIUM DERIVATIVES AS SYNTHETIC COFACTORS FOR THE ENZYME DT DIAPHORASE (NAD(P)H DEHYDROGENASE (QUINONE), EC 1.6.99.2)

被引:45
作者
FRIEDLOS, F
JARMAN, M
DAVIES, LC
BOLAND, MP
KNOX, RJ
机构
[1] INST CANC RES,MOLEC PHARMACOL UNIT,COTSWOLD RD,SUTTON SM2 5NG,SURREY,ENGLAND
[2] INST CANC RES,CHEM DRUG METAB TEAM,DRUG DEV SECT,SUTTON SM2 5NG,SURREY,ENGLAND
关键词
D O I
10.1016/0006-2952(92)90033-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2) is unusual in that it can utilize either NADH or NADPH as a co-factor for the reduction of its substrates. We have shown that the intact NAD(P)H molecule is not required and that other reduced pyridinium compounds can also act as co-factors for DT diaphorase. The entire adenine dinucleotide portion of NAD(P)H can be dispensed with entirely and the simplest quaternary (and therefore reducible) derivative of nicotinamide, 1-methylnicotinamide, was as effective as NAD(P)H as a co-factor for the reduction of the quinone, menadione. Nicotinamide 5'-O-benzoyl riboside was also as effective a co-factors as NAD(P)H, whilst nicotinamide ribotide and riboside have a higher K(m), and decreased the k(cat) of DT diaphorase. Nicotinic acid derivatives had little activity. Kinetic analysis indicated that both nicotinamide ribotide and riboside may be interacting with the menadione binding site rather than the NAD(P)H site. Irrespective of the differences between the various reduced pyridinium derivatives in their ability to act as co-factors for the reduction of menadione by DT diaphorase, all the compounds that showed activity in this assay were equally effective co-factors for the reduction of the nitrobenzamide, CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The apparent K(m) of DT diaphorase for all these co-factors approached zero. It was concluded that co-factor binding is not a rate-limiting step in the nitroreductase activity of DT diaphorase.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 19 条
[11]   THE NITROREDUCTASE ENZYME IN WALKER CELLS THAT ACTIVATES 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB-1954) TO 5-(AZIRIDIN-1-YL)-4-HYDROXYLAMINO-2-NITROBENZAMIDE IS A FORM OF NAD(P)H DEHYDROGENASE (QUINONE) (EC-1.6.99.2) [J].
KNOX, RJ ;
BOLAND, MP ;
FRIEDLOS, F ;
COLES, B ;
SOUTHAN, C ;
ROBERTS, JJ .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4671-4677
[12]  
LIU XF, 1989, MOL PHARMACOL, V35, P818
[13]   ENZYMOLOGY OF THE REDUCTION OF THE POTENT BENZOTRIAZINE-DI-N-OXIDE HYPOXIC CELL CYTOTOXIN SR-4233 (WIN-59075) BY NAD(P)H - (QUINONE ACCEPTOR) OXIDOREDUCTASE (EC 1.6.99.2) PURIFIED FROM WALKER 256 RAT-TUMOR CELLS [J].
RILEY, RJ ;
WORKMAN, P .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (02) :167-174
[14]   CAFFEINE, AMINOIMIDAZOLECARBOXAMIDE AND DICOUMAROL, INHIBITORS OF NAD(P)H DEHYDROGENASE (QUINONE) (DT DIAPHORASE), PREVENT BOTH THE CYTO-TOXICITY AND DNA INTERSTRAND CROSSLINKING PRODUCED BY 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB-1954) IN WALKER CELLS [J].
ROBERTS, JJ ;
MARCHBANK, T ;
KOTSAKIKOVATSI, VP ;
BOLAND, MP ;
FRIEDLOS, F ;
KNOX, RJ .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (22) :4137-4143
[15]  
ROBERTSON JA, 1986, J BIOL CHEM, V261, P5794
[16]  
SIEGEL D, 1990, CANCER RES, V50, P7293
[17]   HUMAN DT-DIAPHORASE, A POTENTIAL CANCER PROTECTING ENZYME - ITS PURIFICATION FROM ABDOMINAL ADIPOSE-TISSUE [J].
SMITH, D ;
MARTIN, LF ;
WALLIN, R .
CANCER LETTERS, 1988, 42 (1-2) :103-112
[18]  
SUGIMURA T, 1966, CANCER RES, V26, P1717
[19]   NAD(P)H-QUINONE OXIDOREDUCTASE (DT-DIAPHORASE) ACTIVITY AND MESSENGER-RNA CONTENT IN NORMAL AND NEOPLASTIC MOUSE LUNG EPITHELIA [J].
THAETE, LG ;
SIEGEL, D ;
MALKINSON, AM ;
FORREST, GL ;
ROSS, D .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) :145-149